Power and sample size calculation for log-rank test with a time lag in treatment effect

Statistics in Medicine

Volumn 28, Issue 5, 2009, Pages 864-879

  Zhang, Daowen ^a   Quan, Hui ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b SANOFI   (France)

Author keywords

Censoring; Intent to treat analysis; Treatment termination

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHI SQUARE DISTRIBUTION; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LOG RANK TEST; MAJOR CLINICAL STUDY; NONPARAMETRIC TEST; POWER ANALYSIS; PROBABILITY; PROPORTIONAL HAZARDS MODEL; SAMPLE SIZE; SIMULATION; ALGORITHM; COMPUTER SIMULATION; EPIDEMIOLOGY; TIME; TREATMENT OUTCOME;

ALGORITHMS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; PROPORTIONAL HAZARDS MODELS; SAMPLE SIZE; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 64549152062     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3501     Document Type: Article

References (10)

1. Cox D. Regression models and life-tables. Journal of the Royal Statistical Society, Series B 1972; 34:187-220.
2. Fleming TR, Harrington DP. Counting Processes and Survival Analysis. Wiley: New York, 1991.
3. Schoenfeld D. The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 1981; 68:316-319.
4. Zucker DM, Lakatos E. Weighted log rank type statistics for comparing survival curves when there is a time lag in the effectiveness of treatment. Biometrika 1990; 77:853-864.
5. Luo X, Turnbull BW, Cai H, Clark LC. Regression for censored survival data with lag effects. Communications in Statistics - Theory and Methods 1994; 23:3417-3438.
6. Schoenfeld DA, Richter JR. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics 1982; 38:163-170.
7. Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 1986; 42:507-519.
8. Lakatos E. Sample sizes based on the log-rank statistic in complex clinical-trials. Biometrics 1988; 44:229-241.
9. Shih JH. Sample size calculation for complex clinical trials with survival endpoints. Controlled Clinical Trials 1995; 16:395-407.
10. Lakatos E, Lan KKG. A comparison of sample size methods for the logrank statistic. Statistics in Medicine 1992; 11:179-191.